- ✓AID systems are now smaller, more accurate, and easier to use than ever before
- ✓Devices from different brands can work together, giving patients more flexibility
- ✓Future systems may include additional medications beyond insulin for even better blood sugar control
| Journal | Journal of diabetes science and technology |
| Year | 2025 |
| Authors | Zisser, Hovorka, Basu |
| PMID | 40590463 |
What Was Studied and Why It Matters
A team of scientists—many of whom personally helped build the technology—published a sweeping review of how automated insulin delivery (AID) systems have evolved over the decades. These are the devices that automatically monitor blood sugar and deliver insulin without you having to calculate every dose manually. Understanding this history helps patients appreciate how much smarter and safer these systems have become, and where they're headed next.
What the Research Found
The review, published in the Journal of Diabetes Science and Technology, traces the journey from the earliest "artificial pancreas" ideas to the sophisticated, fully functional systems available today. Here are the key takeaways:
- Smaller and smarter hardware: The individual components—continuous glucose monitors (CGMs), insulin pumps, and control algorithms—have all shrunk in size while growing dramatically in accuracy and reliability.
- Interoperable systems: Devices from different manufacturers can now work together, giving patients more flexibility and choice rather than being locked into one brand's ecosystem.
- Beyond insulin: Newer AID systems are being designed to work with additional drugs alongside insulin—such as glucagon or pramlintide—to manage blood sugar even more precisely.
- User-friendliness is a priority: Early systems were complex and required significant technical knowledge. Modern systems are designed so that everyday patients and caregivers can use them with confidence.
- Government-backed research: Much of this progress was funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), underscoring the public health importance of this technology.
What This Means for Real Patients
If you or a loved one uses an insulin pump or CGM, this research is a reminder of how rapidly your options are improving. Automated insulin delivery systems reduce the mental burden of diabetes management—fewer manual calculations, fewer dangerous highs and lows, and more time living your life.
For patients who rely on quality supplies to support their diabetes devices, having a dependable source matters. MDS Diabetes provides the diabetes supplies you need to keep these advanced systems running smoothly, from CGM sensors to pump accessories.
Researchers are now exploring systems that could anticipate blood sugar changes before they happen, adapt to exercise and meals automatically, and require even less input from the user. The artificial pancreas of tomorrow may feel almost invisible.
Bottom Line
Automated insulin delivery has gone from a laboratory concept to a life-changing reality—and it keeps getting better. Systems are now smaller, more accurate, and easier to use than ever before, with new medications being added to make them even more effective. Whether you're already using an AID system or considering one, the science is firmly on your side. Talk to your care team about whether automated insulin delivery is right for you, and make sure your supplies are always in order so your technology never lets you down.
